Curis
CRIS
#11008
Rank
NZ$6.1 M
Marketcap
NZ$2.52
Share price
-0.67%
Change (1 day)
-11.05%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): NZ-$40.19

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$40.24. In 2025 the company made an earnings per share (EPS) of NZ-$40.24 an increase over its 2024 EPS that were of NZ-$237.71.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$40.19-0.13%
2025NZ-$40.24-83.07%
2024NZ-$237.71-22.15%
2023NZ-$305.34-26.17%
2022NZ-$413.5522.3%
2021NZ-$338.14-25.37%
2020NZ-$453.11-30.93%
2019NZ-$655.99-2.02%
2018NZ-$669.52
2016NZ-$1,522-10%
2015NZ-$1,691138.1%
2014NZ-$710.0940%
2013NZ-$507.21-25%
2012NZ-$676.2866.67%
2011NZ-$405.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.21-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.02-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.61-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.29-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.20-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$8.52-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$0.29-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA